Characterization of the Co2+ and Ni2+ binding amino‐acid residues of the N‐terminus of human albumin: An insight into the mechanism of a new assay for myocardial ischemia

Abstract

Patients suffering from myocardial ischemia reportedly exhibit reduced in vitro binding of exogenous Co 2+ to the N‐terminal of human serum albumin (HSA). The purpose of our investigation was to simulate changes in the N‐terminus of HSA that may account for these ischemia‐induced modifications to the cobalt binding site. HPLC, LC‐MS and 1 H NMR analyses have shown that the N‐terminal region of HSA Asp‐Ala‐His‐Lys binds the transition metals Co 2+ and Ni 2+. Synthetic peptides with the first 2–12 amino acids of the HSA sequence demonstrated that the first three amino acids, Asp‐Ala‐His, are essential for strong binding of cobalt. Modification of the N‐terminus peptide of HSA by way of N‐acetylation or the deletion of one or more amino acid resulted in no binding of cobalt. Because the degradation of the susceptible, specific transition metal binding site of HSA may account for the decreased cobalt binding observed during ischemic events, an assay that detects this reduced binding could be useful in the diagnosis of ischemia.